Delivery Order SPE2DB24D1104-SPE2DB25FYBQ4
Award Date
6/3/25
Potential Completion Date
6/4/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,940.22 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 6, 2025. The contract has a completion date of March 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $3,816.89 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 3, 2025 with a completion date of April 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $15,251.94 firm-fixed-price delivery order has a completion date of March 1, 2024 and was awarded on February 29, 2024 to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $16,436.31 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024 with a completion date of December 10, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
The federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency, a defense agency. The $1,850.27 fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 19, 2025, with a completion date of May 20, 2025. The contract is not a set-aside and was competed openly. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract with the Defense Logistics Agency Troop...
This federal contract award is for the delivery of 4,564,662,850 units of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $5,905.15 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2024, with a completion date of May 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $17,732.82 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, on August 5, 2024 for delivery by August 6, 2024. The contract does not have a set-aside designation. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award is for the delivery of 4,567,372,778 units of ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $6,665.15 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 25, 2025, with a completion date of February 26, 2025. The contract does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of 4563816196 Ondansetron ODT 4 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA). The $16,342.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The ultimate completion date for this order is March 1, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron ODT 4 mg tablets. The contract, valued at $13,603.15, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 27, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...